MAICD MAICD - Opthea CEO MD
| CKDXF Stock | USD 0.44 0.00 0.00% |
Insider
MAICD MAICD is CEO MD of Opthea
| Age | 48 |
| Phone | 61 3 9826 0399 |
| Web | https://opthea.com |
Opthea Management Efficiency
The company has return on total asset (ROA) of (0.6081) % which means that it has lost $0.6081 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0129) %, meaning that it generated substantial loss on money invested by shareholders. Opthea's management efficiency ratios could be used to measure how well Opthea manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mba MBA | Verastem | 70 | |
| Daniel Calkins | Verastem | 36 | |
| Robert Weinberg | Verastem | N/A | |
| Erin Cox | Verastem | N/A | |
| David Dornan | Elevation Oncology | 46 | |
| Sean Flynn | Verastem | 50 | |
| Christian Mueller | Immutep Ltd ADR | N/A | |
| Ryan Bloomer | Elevation Oncology | N/A | |
| Brian Sullivan | Elevation Oncology | N/A | |
| Jonathan Pachter | Verastem | 66 | |
| Piyush Gupta | Verastem | N/A | |
| Wolfgang MD | Rigel Pharmaceuticals | 58 | |
| RPh PharmD | Elevation Oncology | 40 | |
| Shengfei Fang | Immutep Ltd ADR | N/A | |
| Stephen JD | Geron | 74 | |
| BPHARM RPh | Verastem | 63 | |
| Joseph Ferra | Elevation Oncology | 49 | |
| Valerie MD | Elevation Oncology | 46 | |
| Michelle MD | Verastem | 48 | |
Management Performance
| Return On Equity | -1.01 | |||
| Return On Asset | -0.61 |
Opthea Leadership Team
Elected by the shareholders, the Opthea's board of directors comprises two types of representatives: Opthea inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opthea. The board's role is to monitor Opthea's management team and ensure that shareholders' interests are well served. Opthea's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opthea's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Chief Officer | ||
| MD MBA, Chief Officer | ||
| Michael Gerometta, Manufacturing Chemistry | ||
| Annie Lee, F Mang | ||
| Karen CPA, VP Sec | ||
| Ian Leitch, Director - Clinical Research | ||
| James Goding, Independent Consultant | ||
| MAICD MAICD, CEO MD | ||
| MSc BPHARM, VP Operations |
Opthea Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Opthea a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.01 | |||
| Return On Asset | -0.61 | |||
| Operating Margin | (485.10) % | |||
| Current Valuation | 164.26 M | |||
| Shares Outstanding | 404.98 M | |||
| Shares Owned By Insiders | 8.98 % | |||
| Shares Owned By Institutions | 28.67 % | |||
| Price To Book | 2.75 X | |||
| Price To Sales | 1,669 X | |||
| Revenue | 90.68 K |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Opthea Pink Sheet
When determining whether Opthea is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opthea Pink Sheet is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opthea Stock. Highlighted below are key reports to facilitate an investment decision about Opthea Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Opthea. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Opthea Pink Sheet please use our How to Invest in Opthea guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.